Все публикации

Why you should attend ESMO Asia 2024 - Prof. Long & Prof. van Laarhoven

Why young oncologists should attend ESMO Asia 2024 - Prof. Lim

ESMO 2024: Join your international community in Barcelona, or Online

ESMO Immuno-Oncology 2024: Congress Experts in the field invite you to share your research.

ESMO Women for Oncology Forum 2023: 10 years of ESMO W4O advocating for gender equity

ESMO/ASCO Global Curriculum in Medical Oncology: Insights on the 2023 Edition

Precision Medicine in Prostate Cancer

ESMO Asia Congress 2024: multidisciplinary oncology in the Asian region

Unlock your future: Why Young Oncologists should attend MAP 2024

Recommendations for the use of NGS in patients with metastatic cancer

ESMO Gynaecological Cancers Congress 2024 Members of the Scientific Committee invite you to register

ESMO Sarcoma and Rare Cancers 2024: The Scientific Committee on why you should attend

ESMO Congress 2023 Patient Advocacy Track Testimonial with Barbara Moss

How to select patients with localised soft tissue sarcoma for neoadjuvant/adjuvant chemotherapy?

#ESMOBreast24: International breast cancer experts explain why you should submit your research

#ESMO23: NSCLC, metastatic Track key takeaways with Chair Marina Garassino

#ESMO23 Basic science & Translational research Track: key takeaways with Federica Di Nicolantonio

Highlights on selpercatinib in RET-mutant medullary thyroid cancer: The LIBRETTO-531 study

#ESMO23 Supportive and palliative care: Track highlights with Chair Christina Ruhlmann

#ESMO23 Gastrointestinal tumours (upper) Track highlights with Chair Elizabeth Smyth

ESMO Congress 2023 Virtual Platform

#ESMO23 Head and neck cancer Track highlights with Chair Paolo Bossi

#ESMO23 Investigational immunotherapy Track highlights with Chair Inge Marie Svane

#ESMO23 Developmental therapeutics Track highlights with Chair Lillian Siu